Back to top

Insight Molecular Diagnostics highlights Lancet study on GraftAssure assay

Insight Molecular Diagnostics (IMDX) highlighted the publication of a study in The Lancet Regional Health – Europe, part of the Lancet Group, demon...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Insight Molecular Diagnostics Inc. (IMDX)